Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic men
Metformin-use in obese men is associated with reduced PC risk, if detected early. Further research could inform the repurposing of metformin for PC control.
Authors
- Michael David (ORCID: https://orcid.org/0000-0001-6510-9961)
- Karen Chiam (ORCID: https://orcid.org/0000-0001-8154-6731)
- Albert Bang
- David J. Smith
- Manish I Patel
- Rani Radhika-Chand
- Visalini Nair-Shalliker
Institutions
- Griffith University (AU)
- The University of Sydney (AU)
- Westmead Hospital (AU)
- St Vincent's Hospital Sydney (AU)
- St Vincent's Clinic (AU)
- Monash University (AU)
- Cancer Council NSW (AU)
Publication Details
- Journal
- BJC Reports
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1038/s44276-025-00201-x
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- NSW Ministry of Health
- Cancer Council NSW